-transparent.png){kind=logo}
Fifteen noninfected patients received three consecutive doses of tobramycin (1.7 mg/kg intramuscularly). Serum and bronchial secretions were obtained during bronchoscopy. Microbiologic assay demonstrated that bronchial secretions containing tobramycin produced inappropriately small zone sizes when compared with serum. Also, it was shown that bronchial secretions frequently do achieve therapeutic concentrations of tobramycin at this dosage level and route of administration.
Related Publications
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
September 1973,
Antimicrobial agents and chemotherapy,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1965,
Klinische Wochenschrift,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1981,
Antimicrobial agents and chemotherapy,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1986,
Acta cytologica,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1965,
Archivio di tisiologia e delle malattie dell'apparato respiratorio,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1963,
Exposes annuels de biochimie medicale,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1957,
Archivio italiano di otologia, rinologia e laringologia,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1959,
Journal des sciences medicales de Lille,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
February 1982,
The American review of respiratory disease,
M R Alexander, and
E M Berglund, and
J E Kasik, and
A Fox, and
W M Chinn
January 1994,
European journal of clinical pharmacology,
